Company intelligence / Profile preview

Yantai Zhengfang Pharmaceutical

Yantai, Shandong, Chinaen.ytzhengfang.com ↗

Ownership: Private
Employees: ~118
Development stage: Commercial

Overview

Yantai Zhengfang Pharmaceutical Co., Ltd. operates as a modern pharmaceutical enterprise focused primarily on the development and production of medicines for diabetes, cardiovascular, and cerebrovascular conditions. The company has significant manufacturing capacity with a facility covering an area of 45 mu (~30,000 square meters), employs over 100 staff members, and has invested approximately RMB 100 million in its operations. It produces both health products and pharmaceuticals for the Chinese market.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small molecules
Industry: Biotech

Drug pipeline

2 assets

mitiglinide calcium

Commercial

Indications: Type 2 diabetes

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Yantai Zhengfang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yantai Zhengfang Pharmaceutical.

Explore the full profile